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LETTER TO THE EDITOR
Association of Cardiac Rehabilitation with  
Improvement in High Sensitive C-Reactive  
Protein Post-Myocardial Infarction 
 
 
Dear Editor, 
Atherosclerotic cardiovascular diseases are the ma-
jor cause of death in middle-aged and older-adults.
1,2 
Today, inflammation is regarded as the key patho-
genic mechanism in both initiation and progression 
of atherosclerosis.
3 Inflammatory markers such as 
high sensitive C-reactive protein (CRP) have been 
used to identify patients at higher risk for coronary 
events. The prognostic value of CRP has been estab-
lished for patients with acute coronary syndrome, 
stable coronary artery diseases
4 and in apparently 
healthy people.
5,6 
Comprehensive cardiac rehabilitation is probably 
the most effective approach for cardiovascular reduc-
tion and long-term care of cardiac patients as well as 
subjects with multiple coronary risk factors.
7,8 Sec-
ondary prevention, through cardiac rehabilitation 
program is now regarded as an essential component 
of contemporary management of patients with various 
presentations of coronary disease.
9  
There are some evidences that protective effects of 
cardiac rehabilitation may in part be related to lower-
ing of inflammation. The goal of this prospective 
study was to assess the effect of cardiac rehabilitation 
on high sensitive CRP as a marker of increased risk 
of coronary artery disease. 
The subjects were randomly selected from patients 
with recent anterior wall myocardial infarction refer-
ring to Alzahra Cardiac Rehabilitation Center in Shi-
raz from May to December 2007. Inclusion criteria 
were males and females aged 30-75 years with anteri-
or wall MI in past 1 month. Patients were divided into 
two groups. Group A consisted of 30 participants who 
received cardiac rehabilitation and group B consisting 
of 26 participants which did not receive any cardiac 
rehabilitation program. CRP levels were assessed be-
fore starting the program and eight weeks later. We 
used CRP Quantitative Diagnostic Kit for serum and 
plasma-Photometry technique. The data were ana-
lyzed by Wilcoxon Signed Rank and Mann-Whitney 
tests. 
The cardiac rehabilitation program included 8 
weeks of exercise training, education and behavior 
modification therapy 3 times per week. The exercise 
training included arm and leg ergometry and tread-
mills. Behavioral modifications were smoking cessa-
tion, healthy nutrition, hypertension control, etc.  
The average age of patients was 62.7 years old. At 
enrollment, 66% (n=20) of participants in cardiac re-
habilitation (group A) had CRP levels in the interme-
diate and high-risk range of >1 mg/dl and after com-
pletion of cardiac rehabilitation only 27% (n= 5) of 
patients had elevated CRP levels (p=0.0009). In the 
group B, 73% (n=19) of participants had CRP levels 
>1 mg/dl and after eight weeks, 53% (n=14) of them 
had CRP levels >1 mg/dl (p=0.50). 
A higher CRP level was observed in patients <65 
years of age participating in cardiac rehabilitation 
compared to those >65 years, but both age groups 
demonstrated significant improvements in CRP post-
cardiac rehabilitation. This study showed a significant 
decrease in CRP levels in patients with cardiac dis-
ease after participation in cardiac rehabilitation pro-
gram. The findings showed that cardiac rehabilitation 
decreased vascular inflammation accompanying im-
provement in risk factors. 
Regardless of gender, there was a significant de-
crease in CPR at the completion of cardiac rehabilita-
tion. The decrease in inflammation along with previ-
ously described benefits of cardiac rehabilitation sup-
ports the recommendations of American Heart Asso-
ciation and American Association of Cardiovascular 
and Pulmonary Rehabilitation that participation in 
cardiac rehabilitation should be a part of comprehen-
sive care of cardiac patients. 
The findings in our study had two important clin-
ical implications. First, the potential independent 
effect of cardiac rehabilitation in lowering CRP lev-
els was demonstrated which is independent from 
weight in our study. The non-pharmacologic mecha-
nism for this observation may be due to dietary 
modifications, weight management and exercise 
components of the program. Secondly, the decrease 
in vascular inflammation associated with cardiac 
rehabilitation is evident regardless of gender, age 
and metabolic syndrome. Aminlari et al. 
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